TITLE

Randomized double blind placebo control studies, the "Gold Standard" in intervention based studies

AUTHOR(S)
Misra, Shobha
PUB. DATE
July 2012
SOURCE
Indian Journal of Sexually Transmitted Diseases;Jul-Dec2012, Vol. 33 Issue 2, p131
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies follow a hierarchy in terms of the quality of evidence that they can provide. Randomized double blind placebo control (RDBPC) studies are considered the "gold standard" of epidemiologic studies. And the same is discussed at length in this paper taking example of a real journal article employing this study design to answer the research question; "Does once daily dose of Valacyclovir reduce the risk of transmission of genital herpes in a susceptible partner?" RDBPC studies remain the most convincing research design in which randomly assigning the intervention can eliminate the influence of unknown or immeasurable confounding variables that may otherwise lead to biased and incorrect estimate of treatment effect. Also, randomization eliminates confounding by baseline variables and blinding eliminates confounding by co-interventions, thus eliminating the possibility that the observed effects of intervention are due to differential use of other treatments. The best comparison is placebo control that allows participants, investigators and study staff to be blinded. The advantage of trial over an observational study is the ability to demonstrate causality. Hope, this will be useful to neophyte researchers to understand causal hierarchy when critically evaluating epidemiologic literature.
ACCESSION #
83529378

 

Related Articles

  • A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma. Cui, Chuanliang; Mao, Lili; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Li, Siming; Lian, Bin; Gu, Kangsheng; Tao, Min; Song, Xin; Lin, Tongyu; Ren, Xiubao; Qin, Shukui; Guo, Jun // Molecular Therapy;Jul2013, Vol. 21 Issue 7, p1456 

    Endostatin is a potent endogenous angiogenic inhibitor with implicated antitumor activity. However, efficacy of recombinant human endostatin (rhES) in clinical trials is controversial, and application of rhES in treatment of metastatic melanoma awaits further investigations. This phase II trial...

  • Evaluating the Internal Validity of a Randomized Controlled Trial. Turlik, Michael // Podiatry Management;Mar2010, Vol. 29 Issue 3, p191 

    The article presents a reprint of the article “Evaluating the Internal Validity of a Randomized Controlled Trial,” by Michael Turlik, which appeared in an issue of “The Foot & Ankle Journal.” The author discusses factors influencing internal validity such as bias,...

  • Funding source and the quality of reports of chronic wounds trials: 2004 to 2011. Hodgson, Robert; Allen, Richard; Broderick, Ellen; Bland, J. Martin; Dumville, Jo C.; Ashby, Rebecca; Bell-Syer, Sally; Foxlee, Ruth; Hall, Jill; Lamb, Karen; Madden, Mary; O'Meara, Susan; Stubbs, Nikki; Cullum, Nicky // Trials;2014, Vol. 15 Issue 1, p1 

    Background Critical commentaries suggest that wound care randomised controlled trials (RCTs) are often poorly reported with many methodological flaws. Furthermore, interventions in chronic wounds, rather than being drugs, are often medical devices for which there are no requirements for RCTs to...

  • THE EFFICACY OF CLOBETASOL PROPIONATE WITH VARYING DILUTIONS OF EMOLLIENT DETERMINED BY HISTAMINE WHEAL SUPPRESSION TEST. Barathi, M.; Rai, Reena; Srinivas, C. R. // Indian Journal of Dermatology;Sep/Oct2011, Vol. 56 Issue 5, p527 

    Background: The ability of steroids to reduce the histamine wheal was used to assess the efficacy of topical clobetasol propionate with varying dilutions of emollients. Aim: To determine the wheal-suppressing ability of topical clobetasol with varying dilutions of emollient. Materials and...

  • Blindness in Randomized Controlled Trials. Shamsipour, Mansour // International Journal of Fertility & Sterility;Apr-Jun2010, Vol. 4 Issue 1, p40 

    The article discusses blindness and its importance in randomized controlled trials (RCTs), specifically in clinical trials evaluating therapeutic effects. It defines blinding or masking as the condition wherein study participants, health care providers and evaluators gathering outcome data are...

  • The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review. Bello, Segun; Maoling Wei; Hilden, Jørgen; Hróbjartsson, Asbjørn; Wei, Maoling // BMC Medical Research Methodology;2/13/2016, Vol. 16, p1 

    Background: Blinding is a pivotal method to avoid bias in randomised clinical trials. In blinded drug trials, experimental and control interventions are often designed to be matched, i.e. to appear indistinguishable. It is unknown how often matching procedures are inadequate, so we...

  • Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects. Kay, Gary G.; Staskin, David R.; MacDiarmid, Scott; McIlwain, Marilyn; Dahl, Naomi V. // Clinical Drug Investigation;2012, Vol. 32 Issue 10, p707 

    Background and Objective: Oxybutynin is a common antimuscarinic therapy for overactive bladder. Transdermally administered oxybutynin chloride topical gel 10% (OTG) has a low propensity for anticholinergic adverse effects and possibly also a low risk of cognitive impairment. A randomized,...

  • Intra-operative paravertebral block for postoperative analgesia in thoracotomy patients: a randomized, double-blind, placebo-controlled study Helms, Olivier; Mariano, Juliette; Hentz, Jean-Gustave; Santelmo, Nicola; Falcoz, Pierre-Emmanuel; Massard, Gilbert; Steib, Annick // European Journal of Cardio-Thoracic Surgery;Oct2011, Vol. 40 Issue 4, p902 

    Abstract: Objective: Epidural analgesia is the gold standard for post-thoracotomy pain relief but is contraindicated in certain patients. An alternative is paravertebral block. We investigated whether ropivacaine, administered through a paravertebral catheter placed by the surgeon, reduced...

  • Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study. Wang, Man; Tong, Jian-hua; Huang, De-sheng; Zhu, Gang; Liang, Guang-ming; Du, Hong // Psychopharmacology;Jul2014, Vol. 231 Issue 14, p2811 

    Rationale and objective: Depression symptoms are now recognized to be the predominant cause of disability for bipolar disorder (BD) patients. The treatment strategies for the depressed phase of BD remain more anecdotal than data-based. Olanzapine has been investigated as an alternative to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics